Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With Sepsis

计划入组 1 人 · 首次发布于 2014 年 7 月 2 日

Early Intervention Coping Kids (TIM) Follow up Study

计划入组 217 人 · 首次发布于 2023 年 3 月 13 日

Cultural Adaptation of the TIM&SARA Prevention Program

计划入组 740 人 · 首次发布于 2019 年 2 月 5 日

TIM-063

TIM-098a

TIM-3-Fc-OX40L

Xi'an No.4 Hospital

China

Guiyang No.4 People's Hospital

China

Huai'an No.4 People's Hospital

China

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board as Oral TIM-3/TIM-4 Agonist Advances Through Phase 1b Trials

CERo Therapeutics' CER-1236 Shows Promise in Preclinical Ovarian Cancer Models

FDA Clears CERo Therapeutics' IND for Novel CAR-T Therapy CER-1236 in Solid Tumors